2014
DOI: 10.1186/1472-6874-14-93
|View full text |Cite
|
Sign up to set email alerts
|

Effect of metformin on serum interleukin-6 levels in polycystic ovary syndrome: a systematic review

Abstract: BackgroundMost women with polycystic ovary syndrome (PCOS) have insulin resistance, hyperinsulinemia, and elevated serum IL-6 levels. These elevated IL-6 levels may have links with insulin resistance and hyperandrogenism. Metformin may have beneficial effects on the chronic low-grade inflammatory background associated with PCOS.MethodsA systematic review was performed via PUBMED, EMBASE, and The Cochrane Library on PCOS studies published through November 30, 2013. Studies were selected that evaluated the effec… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
29
1
2

Year Published

2015
2015
2024
2024

Publication Types

Select...
6
1
1

Relationship

1
7

Authors

Journals

citations
Cited by 56 publications
(32 citation statements)
references
References 21 publications
0
29
1
2
Order By: Relevance
“…Most women with PCOS have insulin resistance, hyperinsulinemia, and elevated serum IL-6 levels. A recent meta-analysis suggested that the serum IL-6 levels of PCOS patients may be influenced by metformin, and early application of metformin therapy may relieve chronic lowgrade inflammation in women with PCOS [33]. Moreover, a similar positive association with the IL-6 -174 site was found for Alzheimer's disease and cancer, which are also recognized as inflammation-related diseases [34].…”
Section: Discussionmentioning
confidence: 93%
“…Most women with PCOS have insulin resistance, hyperinsulinemia, and elevated serum IL-6 levels. A recent meta-analysis suggested that the serum IL-6 levels of PCOS patients may be influenced by metformin, and early application of metformin therapy may relieve chronic lowgrade inflammation in women with PCOS [33]. Moreover, a similar positive association with the IL-6 -174 site was found for Alzheimer's disease and cancer, which are also recognized as inflammation-related diseases [34].…”
Section: Discussionmentioning
confidence: 93%
“…In a previous study, serum IL-6 level in polycystic ovary syndrome (PCOS) patients was influenced by metformin. In this study, most women with PCOS suffered from insulin resistance, hyperinsulinemia, and elevated serum IL-6 level (45).…”
Section: Discussionmentioning
confidence: 99%
“…Metformin is a natural molecule (originally extracted and modifi ed from the French lilac Galega offi cinalis ), with insulin-lowering effects by improving insulin sensitivity and, in turn, decreases circulating androgen levels. A recent systematic review showed a signifi cant reduction of IL-6 by metformin in agreement with its role in improving insulin receptors damaged by low-grade infl ammation in overweight-obese women affected by PCOS [ 40 ].…”
Section: Nutritional Interventionsmentioning
confidence: 90%